Array BioPharma, Inc. (NASDAQ:ARRY)

CAPS Rating: 3 out of 5

A biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life threatening and debilitating diseases.

Recs

0
Player Avatar gunterle (64.49) Submitted: 7/16/2012 1:30:43 PM : Outperform Start Price: $3.66 ARRY Score: -9.74

signal

Featured Broker Partners


Advertisement